Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Cassava Sciences Inc - Warrants (15/11/2024)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cassava Sciences Inc - Warrants (15/11/2024) 52 week high is $11.02 as of September 13, 2025.
What is the 52-week low for Cassava Sciences Inc - Warrants (15/11/2024)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cassava Sciences Inc - Warrants (15/11/2024) 52 week low is $0.0203 as of September 13, 2025.
What is Cassava Sciences Inc - Warrants (15/11/2024) stock price today?
What is the 50-day moving average of Cassava Sciences Inc - Warrants (15/11/2024)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cassava Sciences Inc - Warrants (15/11/2024) 50-day moving average is $2.85.